The biopersistence of Brazilian chrysotile asbestos following inhalation

Inhalation Toxicology

Volumn 16, Issue 11-12, 2004, Pages 745-761

  Bernstein, David M ^a   Rogers, Rick ^b   Smith, Paul ^a  

^a Rogers Imaging Corporation ^*  (Switzerland)

^b Research and Consulting Company Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHRYSOTILE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAZIL; BRONCHIOLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; LOW TEMPERATURE; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LYMPHOID TISSUE; MALE; MINING; NONHUMAN; PARTICLE SIZE; PATHOGENICITY; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

AIR; ANIMALS; ASBESTOS, SERPENTINE; ATMOSPHERE EXPOSURE CHAMBERS; CARCINOGENS; HALF-LIFE; IMAGE PROCESSING, COMPUTER-ASSISTED; INHALATION EXPOSURE; LUNG; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS;

ANIMALIA; CANA;

EID: 4544295731     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370490490176     Document Type: Article

References (46)

1. Atkinson, R. J. 1973. Chrysotile asbestos: Colloidal silica surfaces in acidified suspensions. J. Colloid Interface Sci. 42:624-628.
2. Agency for Toxic Substances and Disease Registry. 2003. Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers: The Influence of fiber length. Atlanta, GA: Prepared for Agency for Toxic Substances and Disease Registry, Division of Health Assessment and Consultation.
3. Bellmann, B., Muhle, H., Creutzenberg, O., Ernst, H., Muller, M., Bernstein, D. M., and Riego Sintes, J. M. 2003. Calibration study on subchronic inhalation toxicity of man-made vitreous fibers in rats. Inhal. Toxicol. 15(12):1147-1177.
4. Berman, D. W., Crump, K. S., Chatfield, E. J., Davis, J. M., and Jones, A. D. 1995. The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal. 15(2):181-195.
5. Berman, D. W., and Crump, K. S. 2004. Technical support document for a protocol to assess asbestos-related risk. Washington, DC: Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency.
6. Bernstein, D. M., Chevalier, J., and Smith, P. 2003a. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure. Inhal. Toxicol. 15(14):1387-1419.
7. Bernstein, D. M., Mast, R., Anderson, R., Hesterberg, T. W., Musselman, R., Kamstrup, O., and Hadley, J. 1994. An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals. Environ. Health Perspect. 102(Suppl. 5):15-18.
8. Bernstein, D. M., Riego Sintes, J. M., Ersboell, B. K., and Kunert, J. 2001a. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal. Toxicol. 13(10):823-849.
9. Bernstein, D. M., Riego Sintes, J. M., Ersboell, B. K., and Kunert, J. 2001b. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumor response in rats. Inhal. Toxicol. 13(10):851-875.
10. Bernstein, D. M., and Riego-Sintes, J. M. R. 1999. Methods for the determination of the hazardous properties for human health of man made mineral fibers (MMMF). Vol. EUR 18748 EN, April. 93, http://ecb.ei.jrc.it/DOCUMENTS/ Testing-Methods/mmmfweb. pdf. European Commission Joint Research Centre, Institute for Health and Consumer Protection, Unit, Toxicology and Chemical Substances, European Chemicals Bureau.
11. Bernstein, D. M., Rogers, R., and Smith, P. 2003b. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal. Toxicol. 15(13):1247-1274.
12. Bernstein, D. M., Rogers, R., and Smith P. 2004. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal. Toxicol. In press.
13. Bolton, R. E., Vincent, J. H., Jones, A. D., Addison, J., and Beckett, S. T., 1983. An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. Br. J. Ind. Med. 40:264-272.
14. Brismar, H., Patwardhan, A., G. Jaremko, and Nyengaard, J. 1996. Thickness estimation of fluorescent sections using a CLSM. J. Microsc. 184(2):106-116.
15. Cannon, W. C., Blanton, E. F., and McDonald, K. E. 1983. The flow-past chamber: An improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. J. 44(12):923-928.
16. Cossette, M., and Delvaux, P. 1979. Technical evaluation of chrysotile asbestos ore bodies. In Short course in mineralogical techniques of asbestos determination, ed. R. C. Ledoux. Mineralogical Association of Canada, Toronto, Canada, pp. 79-109, May.
17. Cruxên Barros de Oliveira, M. 1989. Mineralogical analysis chrysotile, tech rep 36 889. CEP 01064-970 São Paulo, Brazil: IPT, Institute de Pesquisas Tecnológicas.
18. Davis, J. M., Addison, J., Bolton, R. E., Donaldson, K., Jones, A. D., and Smith, T. 1986. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br. J. Exp. Pathol. 67(3):415-430.
19. EPA. 2003. Report on the Peer Consultation Workshop to discuss a proposed protocol to assess asbestos-related risk. Prepared for U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response, Washington, DC 20460, EPA Contract No, 68-C-98-148, Work Assignment 2003-05. Prepared by Eastern Research Group, Inc., 110 Hartwell Avenue, Lexington, MA 02421. Final Report May 30, 2003.
20. Etherington, D. J., Pugh, D., and Silver, I. A. 1981. Collagen degradation in an experimental inflammatory lesion: Studies on the role of the macrophage. Acta Biol. Med. Ger. 40(10-11):1625-1636.
21. Hargreaves, A., and Taylor, W. H. 1946. An x-ray examination of decomposition products of chrysotile (asbestos) and serpentine. Mineral. Mag. 27:204-216.
22. Hesterberg, T. W., Chase, G., Axten, C., Miller, W. C., Musselman, R. P., Kamstrup, O., Hadley, J., Morscheidt, C., Bernstein, D. M., and Thevenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol. Appl. Pharmacol. 151(2):262-275.
23. Hodgson, A. A. 1979. Chemistry and physics of asbestos. In Asbestos: Properties, applications and hazards, eds. by L. M. Chissick and S. S. Chissick, pp. 80-81. New York: John Wiley & Sons.
24. Hodgson, J. T., and Darnton, A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann. Occup. Hyg. 44(8):565-601.
25. Ilgren, E., and Chatfield, E. 1997. Coalinga fibre-A short, amphibole-free chrysotile. Evidence for lack of fibrogenic activity. Indoor Built Environ. 6:264-276.
26. Ilgren, E., and Chatfield, E. 1998. Coalinga fibre-A short, amphibole-free chrysotile part 2: Evidence for lack of tumourigenic activity. Indoor Built Environ. 7:18-31.
27. Ilgren, E., and Chatfield, E. 1998b. Coalinga fibre: A short, amphibole-free chrysotile, part 3: Lack of biopersistence. Indoor Built Environ. 7:98-109.
28. Kamstrup, O., Davis, J. M., Ellehauge, A., and Guldberg, M. 1998. The biopersistence and pathogenicity of man-made vitreous fibres after short-and long-term inhalation. Ann. Occup. Hyg. 42(3):191-199.
29. Kiyohara, P. K. 1991. Estudo da interface crisotila-cimento Portland em compósitos de fibro-cimento par métodos óptico- eletrônicos., Tese de Doutorado, apres. São Paulo:EPUSP.
30. Mattson, St. M. 1994. Glass fibres in simulated lung fluid: Dissolution behavior and analytical requirements. Ann. Occup. Hyg. 38:857-877.
31. McDonald, J. C., and McDonald, A. D. 1997. Chrysotile, tremolite and carcinogenicity. Ann. Occup. Hyg. 41(6):699-705.
32. Morrow, P. E. 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol. 10(3):369-384.
33. Muhle, H., Pott, F., Bellmann, B., Takenaka, S., and Ziem, U. 1987. Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann. Occup. Hyg. 31(4B):755-764.
34. Nagy, B., and Bates, T. F. 1952. Stability of chrysotile asbestos. Am. Mineral. 37:1055-1058.
35. Oberdorster, G. 1995. Lung particle overload: implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 21(1):123-135.
36. Pott, R, Ziem, U., Reiffer, F. J., Huth, F., Ernst, H., and Mohr, U. 1987. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp. Pathol. 32(3):129-152.
37. Raabe, O. G., Yeh, H. C., Newton, G. J., Phalen, R. F., and Velasquez, D. J. 1977. Deposition of inhaled monodisperse aerosols in small rodents. In Inhaled particles IV, ed. W. H. Wallon, Proceedings of an international symposium organized by the British Occupational Hygiene Society, Edinburgh, 22-26 September 1975, vol. 1, pp. 3-21. Oxford: Pergamon Press.
38. Rittinghausen, S., Ernst, H., Muhle, H., and Mohr, U. 1992. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp. Toxicol. Pathol. 44(1):55-58.
39. Rogers, R. A., Antonini, J. M., Brismar, H., Lai, J., Hesterberg, T. W., Oldmixon, E. H., Thevenaz, P., and Brain, J. D. 1999. In situ microscopic analysis of asbestos and synthetic vitreous fibers retained in hamster lungs following inhalation. Environ. Health Perspect. 107(5):367-375.
40. Skinner, H. C. W., Ross, M., and Frondel, C. eds. 1988. Asbestos and Other Fibrous minerals. Oxford University Press.
41. Smith, R. W. 1973. Aqueous Surface Chemistry of Asbestos Minerals. National Inst. for Occupational Safety and Health, Cincinnati, OH. (Code: HEWOSH), Report number: PHS-OH-00332, NTIs Number: PB90-100942INZ. April.
42. Speil, S., and Leineweber, J. P. 1969. Asbestos minerals in modern technology. Environ. Research 2:166-208.
43. Stoeber, W., Flachsbart, H., and Hochrainer, D. 1970. Der Aerodynamische Durchmesser von Latexaggregaten und Asbestfassern. Staub-Reinh. Luft. 30:277-285.
44. Wagner, J. C., Berry, G., Skidmore, J. W., and Pooley, F. D. 1980. The comparative effects of three chrysotiles by injection and inhalation in rats. IARC Sci. Publ 30:363-372.
45. Weibel, E. R. 1984. The pathway for oxygen. Cambridge, MA: Harvard University Press.
46. World Health Organization 1985. Reference methods for measuring airborne man-made mineral fibres (MMMF), WHO/EURO MMMF reference scheme, Ed. WHO EURO Technical Committee for Monitoring and Evaluating Airborne MMMP, Vol. EH-4. Copenhagen: WHO.